U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ACHIRAL
Molecular Formula C19H20N6O.2ClH
Molecular Weight 421.324
Optical Activity NONE
Defined Stereocenters 0 / 0
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of IMIDOCARB HYDROCHLORIDE

SMILES

Cl.Cl.O=C(NC1=CC=CC(=C1)C2=NCCN2)NC3=CC=CC(=C3)C4=NCCN4

InChI

InChIKey=MLRXMTYSQKIKAK-UHFFFAOYSA-N
InChI=1S/C19H20N6O.2ClH/c26-19(24-15-5-1-3-13(11-15)17-20-7-8-21-17)25-16-6-2-4-14(12-16)18-22-9-10-23-18;;/h1-6,11-12H,7-10H2,(H,20,21)(H,22,23)(H2,24,25,26);2*1H

HIDE SMILES / InChI
Imidocarb is a carbanilide derivative with antiprotozoal activity. It is usually administered as the dipropionate salt. Imidocarb is a drug sold under the brand name Imizol and is used to treat canine ehrlichiosis. wo mechanisms of action have been proposed: As the effect of imidocarb on Trypanosoma brucei is antagonized by excess polyamines, it is has been suggested that imidocarb interferes with their production and/or use. Imidocarb blocks the entry of inositol into erythrocytes containing Babesia, resulting in starvation of the parasite. It is generally accepted in that imidocarb has anticholinesterase activity.

Approval Year

Targets

Targets

Primary TargetPharmacologyConditionPotency
590.0 nM [IC50]
Conditions

Conditions

ConditionModalityTargetsHighest PhaseProduct
Curative
Imizol

Approved Use

For the treatment of babesiosis in dogs with clinical signs and/or demonstrated Babesia organisms in the blood.

Launch Date

1997
Curative
IMIDOCARB

Approved Use

For treatment of babesiosis in cattle and horses

Launch Date

2001
PubMed

PubMed

TitleDatePubMed
Cationic antitrypanosomal and other antimicrobial agents in the therapy of experimental Pneumocystis carinii pneumonia.
1988 Jun
Treatment of experimental pneumocystosis: review of 7 years of experience and development of a new system for classifying antimicrobial drugs.
1992 Sep
Determination of whole blood cholinesterase in different animal species using specific substrates.
2001 Jun
Depletion and bioavailability of imidocarb residues in sheep and goat tissues.
2002 Apr
Electron microscopic investigations on stages of dog piroplasms cultured in vitro: Asian isolates of Babesia gibsoni and strains of B. canis from France and Hungary.
2002 Jan
Evaluation of certain veterinary drug residues in food.
2003
First isolation and molecular characterization of Ehrlichia canis in Spain.
2004 Nov 10
Identification of anti-babesial activity for four ethnoveterinary plants in vitro.
2005 Jun 10
Pharmacokinetics and mammary elimination of imidocarb in sheep and goats.
2006 Jul
Flow cytometric evaluation of selected antimicrobial efficacy for clearance of Anaplasma marginale in short-term erythrocyte cultures.
2006 Jun
Effect of imidocarb and levamisole on the experimental infection of BALB/c mice by Leishmania (Leishmania) amazonensis.
2006 Jun 30
Clinicopathological changes and effect of imidocarb therapy in dogs experimentally infected with Babesia canis.
2006 Mar
Chemotherapy against babesiosis.
2006 May 31
Histological and ultrastructural studies of renal lesions in Babesia canis infected dogs treated with imidocarb.
2007 Dec
Canine vector-borne diseases in Brazil.
2008 Aug 8
Treatment of Mycoplasma wenyonii infection in cows with imidocarb dipropionate injection-acupuncture.
2008 Dec
Repeated high dose imidocarb dipropionate treatment did not eliminate Babesia caballi from naturally infected horses as determined by PCR-reverse line blot hybridization.
2008 Feb 14
Detection of persistent Cytauxzoon felis infection by polymerase chain reaction in three asymptomatic domestic cats.
2008 Jul
An unusual form of canine babesiosis.
2008 Mar
Putative clinical piroplasmosis in a Burchell's zebra (Equus quagga burchelli).
2009 Dec
Detection of a large unnamed Babesia piroplasm originally identified in dogs in North Carolina in a dog with no history of travel to that state.
2009 Oct 1
Failure of imidocarb dipropionate to eliminate Hepatozoon canis in naturally infected dogs based on parasitological and molecular evaluation methods.
2010 Aug 4
First case of babesiosis caused by Babesia canis canis in a dog from Norway.
2010 Aug 4
Haemotropic mycoplasmas: what's their real significance in cats?
2010 May
Detection of Babesia divergens in southern Norway by using an immunofluorescence antibody test in cow sera.
2010 Oct 6
Patents

Sample Use Guides

In Vivo Use Guide
Use intramuscularly or subcutaneously at a rate of 6.6 mg/kg (3 mg/lb) body weight. Repeat the dose in two (2) weeks, for a total of two (2) treatments.
Route of Administration: Other
In Vitro Use Guide
The concentration of Imidocarb causing 50% inhibition of [3H]hypoxanthine incorporation (ID50 value) by Babesia bovis (Lismore and Samford isolates) cultured in vitro for Imidocarb was determined to be 3 ng/ml (8.6 nM).
Name Type Language
IMIDOCARB HYDROCHLORIDE
MART.   USAN  
USAN  
Official Name English
IMIDOCARB HYDROCHLORIDE [USAN]
Common Name English
NSC-51189
Code English
N,N'-BIS(3-(4,5-DIHYDRO-1H-IMIDAZOL-2-YL)PHENYL)UREA DIHYDROCHLORIDE
Systematic Name English
IMIDOCARB DIHYDROCHLORIDE
MI  
Common Name English
UREA, N,N'-BIS(3-(4,5-DIHYDRO-1H-IMIDAZOL-2-YL)PHENYL)-, DIHYDROCHLORIDE
Common Name English
IMIDOCARB HYDROCHLORIDE [MART.]
Common Name English
IMIDOCARB DIHYDROCHLORIDE [MI]
Common Name English
4A65
Code English
IMIDOCARB HCL
Common Name English
3,3'-DI-2-IMIDAZOLIN-2-YLCARBANILIDE DIHYDROCHLORIDE
Common Name English
Classification Tree Code System Code
NCI_THESAURUS C277
Created by admin on Fri Dec 15 15:21:23 GMT 2023 , Edited by admin on Fri Dec 15 15:21:23 GMT 2023
Code System Code Type Description
EPA CompTox
DTXSID30201240
Created by admin on Fri Dec 15 15:21:23 GMT 2023 , Edited by admin on Fri Dec 15 15:21:23 GMT 2023
PRIMARY
SMS_ID
300000023746
Created by admin on Fri Dec 15 15:21:23 GMT 2023 , Edited by admin on Fri Dec 15 15:21:23 GMT 2023
PRIMARY
MERCK INDEX
m6226
Created by admin on Fri Dec 15 15:21:23 GMT 2023 , Edited by admin on Fri Dec 15 15:21:23 GMT 2023
PRIMARY Merck Index
NCI_THESAURUS
C76422
Created by admin on Fri Dec 15 15:21:23 GMT 2023 , Edited by admin on Fri Dec 15 15:21:23 GMT 2023
PRIMARY
ChEMBL
CHEMBL427342
Created by admin on Fri Dec 15 15:21:23 GMT 2023 , Edited by admin on Fri Dec 15 15:21:23 GMT 2023
PRIMARY
ECHA (EC/EINECS)
226-179-7
Created by admin on Fri Dec 15 15:21:23 GMT 2023 , Edited by admin on Fri Dec 15 15:21:23 GMT 2023
PRIMARY
NSC
51189
Created by admin on Fri Dec 15 15:21:23 GMT 2023 , Edited by admin on Fri Dec 15 15:21:23 GMT 2023
PRIMARY
PUBCHEM
21388
Created by admin on Fri Dec 15 15:21:23 GMT 2023 , Edited by admin on Fri Dec 15 15:21:23 GMT 2023
PRIMARY
FDA UNII
KCC1V76AH8
Created by admin on Fri Dec 15 15:21:23 GMT 2023 , Edited by admin on Fri Dec 15 15:21:23 GMT 2023
PRIMARY
CAS
5318-76-3
Created by admin on Fri Dec 15 15:21:23 GMT 2023 , Edited by admin on Fri Dec 15 15:21:23 GMT 2023
PRIMARY